Back to Infectious Disease
Infectious Diseasev2020Evidence-Based

4C Mortality Score for COVID-19

Predicts in-hospital mortality in patients admitted with COVID-19

Clinical Input Parameters

years
Range: 0 — 120 years
comorbidities
Range: 0 — 20 comorbidities
breaths/min
Range: 5 — 60 breaths/min
%
Range: 50 — 100 %
points
Range: 3 — 15 points
variable
Range: 0.1 — 300 variable
mg/L
Range: 0 — 1000 mg/L
Clinical Assessment
Awaiting Parameters
4c score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The 4C Mortality Score for COVID-19 is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within infectious disease.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Points = Age (0-7) + Sex (0-1) + Comorbidities (0-2) + RR (0-2) + SpO2 (0-2) + Glasgow (0-2) + Urea (0-3) + CRP (0-2)

Clinical Pearls & Practice Notes

  • Apply only to hospitalized patients with confirmed COVID-19
  • Comorbidities include: chronic heart disease, chronic lung disease (except asthma), CKD (GFR ≤30), mild-severe liver disease, dementia, chronic neurological diseases, connective tissue diseases, diabetes, HIV/AIDS, malignancy
  • Developed using data from the ISARIC4C consortium of UK patients
  • Validated in multiple international populations
  • Does not apply to outpatient or emergency department patients

Evidence & Literature Citations

  1. Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;370:m3339.
  2. Gupta RK, Marks M, Samuels THA, et al. Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study. Eur Respir J. 2020;56(6):2003498.

Score Interpretation Ranges

Low Risk0 – 3 pts

Low mortality risk

Intermediate Risk4 – 8 pts

Intermediate mortality risk

High Risk9 – 14 pts

High mortality risk

Very High Risk15 – 21 pts

Very high mortality risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.